FDA response to NDI filing underscores CBD’s regulatory challenges – Natural Products INSIDER September 9, 2021 No Comments FDA response to NDI filing underscores CBD’s regulatory challenges Natural Products INSIDER * This article was originally published here Tags: cannabis, cbd